Cargando…

Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

BACKGROUND: The effect of interferon(IFN) in the management of hepatocellular carcinoma (HCC) remains controversial, and no clear recommendations have been proposed. OBJECTIVES: To evaluate the effect and safety of IFN for HCC. METHODS: PubMed, OvidSP, and Cochrane Library were searched from their e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Liping, Zeng, Xiantao, Yang, Zongguo, Meng, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775819/
https://www.ncbi.nlm.nih.gov/pubmed/24069133
http://dx.doi.org/10.1371/journal.pone.0061361
_version_ 1782477427969097728
author Zhuang, Liping
Zeng, Xiantao
Yang, Zongguo
Meng, Zhiqiang
author_facet Zhuang, Liping
Zeng, Xiantao
Yang, Zongguo
Meng, Zhiqiang
author_sort Zhuang, Liping
collection PubMed
description BACKGROUND: The effect of interferon(IFN) in the management of hepatocellular carcinoma (HCC) remains controversial, and no clear recommendations have been proposed. OBJECTIVES: To evaluate the effect and safety of IFN for HCC. METHODS: PubMed, OvidSP, and Cochrane Library were searched from their establishment date until August 30, 2012. Studies that met the inclusion criteria were systematically evaluated and then subjected to meta-analysis. RESULTS: Thirteen randomized control trials (RCTs) involving 1344 patients were eligible for this study. When IFN was used as an adjuvant therapy for HCC patients after curative therapy, the meta-analysis showed that IFN reduced the 1-, 2-, 3-, 4-, and 5-year recurrence rates. Subgroup analysis showed that IFN reduced the 2-, 3-, 4-, and 5-year recurrence rates of hepatitis C viral (HCV)-related HCC. The effect of IFN for on hepatitis B virus(HBV)-related HCC patients could not be determined because of isufficient data. After surgical resection, adjuvant IFN therapy reduced the 4- and 5- recurrence rates. All studies reported that IFN could not improve the overall survival of HCV-realated HCC patients after curative therapies. Only one study showed that IFN was associated with better overall survival in HCC patients after curative therapy and subgroup of HCC patients after surgical resection. Thus, meta-analysis was not performed. Different treatment options were used as control to study the effect of IFN for intermediate and advanced HCC patients, thus meta-analysis was not appropriate. All included studies, except for one, reported that IFN treatment was well tolerated. CONCLUSIONS: After curative therapies, adjuvant IFN reduced the recurrence of HCC. IFN did not improve the survival of HCV-related HCC patients after curative therapy. Whether IFN is effective for intermediate and advanced HCC patients could not be determined because of insufficient data. The toxicity of IFN was acceptable.
format Online
Article
Text
id pubmed-3775819
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37758192013-09-25 Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis Zhuang, Liping Zeng, Xiantao Yang, Zongguo Meng, Zhiqiang PLoS One Research Article BACKGROUND: The effect of interferon(IFN) in the management of hepatocellular carcinoma (HCC) remains controversial, and no clear recommendations have been proposed. OBJECTIVES: To evaluate the effect and safety of IFN for HCC. METHODS: PubMed, OvidSP, and Cochrane Library were searched from their establishment date until August 30, 2012. Studies that met the inclusion criteria were systematically evaluated and then subjected to meta-analysis. RESULTS: Thirteen randomized control trials (RCTs) involving 1344 patients were eligible for this study. When IFN was used as an adjuvant therapy for HCC patients after curative therapy, the meta-analysis showed that IFN reduced the 1-, 2-, 3-, 4-, and 5-year recurrence rates. Subgroup analysis showed that IFN reduced the 2-, 3-, 4-, and 5-year recurrence rates of hepatitis C viral (HCV)-related HCC. The effect of IFN for on hepatitis B virus(HBV)-related HCC patients could not be determined because of isufficient data. After surgical resection, adjuvant IFN therapy reduced the 4- and 5- recurrence rates. All studies reported that IFN could not improve the overall survival of HCV-realated HCC patients after curative therapies. Only one study showed that IFN was associated with better overall survival in HCC patients after curative therapy and subgroup of HCC patients after surgical resection. Thus, meta-analysis was not performed. Different treatment options were used as control to study the effect of IFN for intermediate and advanced HCC patients, thus meta-analysis was not appropriate. All included studies, except for one, reported that IFN treatment was well tolerated. CONCLUSIONS: After curative therapies, adjuvant IFN reduced the recurrence of HCC. IFN did not improve the survival of HCV-related HCC patients after curative therapy. Whether IFN is effective for intermediate and advanced HCC patients could not be determined because of insufficient data. The toxicity of IFN was acceptable. Public Library of Science 2013-09-17 /pmc/articles/PMC3775819/ /pubmed/24069133 http://dx.doi.org/10.1371/journal.pone.0061361 Text en © 2013 Zhuang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zhuang, Liping
Zeng, Xiantao
Yang, Zongguo
Meng, Zhiqiang
Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
title Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
title_full Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
title_fullStr Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
title_full_unstemmed Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
title_short Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
title_sort effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775819/
https://www.ncbi.nlm.nih.gov/pubmed/24069133
http://dx.doi.org/10.1371/journal.pone.0061361
work_keys_str_mv AT zhuangliping effectandsafetyofinterferonforhepatocellularcarcinomaasystematicreviewandmetaanalysis
AT zengxiantao effectandsafetyofinterferonforhepatocellularcarcinomaasystematicreviewandmetaanalysis
AT yangzongguo effectandsafetyofinterferonforhepatocellularcarcinomaasystematicreviewandmetaanalysis
AT mengzhiqiang effectandsafetyofinterferonforhepatocellularcarcinomaasystematicreviewandmetaanalysis